Clinical Trial Update: IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating IL-6 inhibition to modulate inflammation after cardiac arrest has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Arrest
• Out-of-hospital Cardiac Arrest
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Christian Hassager | Conditions: Heart Arrest, Out-Of-Hospital Cardiac Arrest | Phase 2 | Status: COMPLETED